Question 1

What is the catalog number for (D-Phe12)-Bombesin?

Accepted Answer

The catalog number for (D-Phe12)-Bombesin is H-3038.0025.

Question 2

Is (D-Phe12)-Bombesin in stock?

Accepted Answer

(D-Phe12)-Bombesin is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Who manufactures (D-Phe12)-Bombesin?

Accepted Answer

(D-Phe12)-Bombesin is manufactured by Bachem.

Question 4

What is the estimated delivery time for (D-Phe12)-Bombesin?

Accepted Answer

Estimated delivery time for (D-Phe12)-Bombesin is approximately 10 business day(s), depending on your location.

Question 5

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 6

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 7

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

(D-Phe12)-Bombesin

Product Specifications

Frequently Asked Questions

Explore Other Products

Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker), CF568 conjugate, 0.1mg/mL

di-tert-butyl 2,2'-(((2R,5R)-1-(3,5-difluoro-4-(4-(4-fluorophenyl)piperidin-1-yl)phenyl)pyrrolidine-2,5-diyl)bis(6-fluoro-1H-benzo[d]imidazole-5,2-diyl))(2S,2'S)-bis(pyrrolidine-1-carboxylate)

RBBP9 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI4E1]

OR4M1 Human Gene Knockout Kit (CRISPR)

Mouse Egr2 activation kit by CRISPRa

SART1 Human Gene Knockout Kit (CRISPR)